1,057
Views
14
CrossRef citations to date
0
Altmetric
Letters to the Editor

Central Serous Chorioretinopathy Associated with Topical Latanoprost Therapy

, MD, , MD, , MD, , MD & , MD
Pages 453-455 | Received 09 Dec 2010, Accepted 30 Aug 2011, Published online: 22 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sepehr Bahadorani, Kyle Maclean, Kendall Wannamaker, Edward Rickie Chu, Nathan Gresores, Jeong-Hyeon Sohn, Roberto Diaz-Rohena & Michael A Singer. (2019) Treatment of central serous chorioretinopathy with topical NSAIDs. Clinical Ophthalmology 13, pages 1543-1548.
Read now
Zeynep Duru, Cemal Özsaygılı, Döndü Melek Ulusoy, Atılım Armağan Demirtaş, Ayşe Çiçek & Necati Duru. (2019) Does using topical latanoprost affect subfoveal choroidal thickness?. Cutaneous and Ocular Toxicology 38:4, pages 370-374.
Read now

Articles from other publishers (12)

Ihsan Cakir, Seren Pehlivanoglu, Gulay Yalcinkaya & Cigdem Altan. (2022) The Effect of Latanoprost on Choroidal Vascularity Index in Glaucoma and Ocular Hypertension. Journal of Glaucoma 31:12, pages 972-978.
Crossref
Manish Jain, Dhanya Kurian, Sarath Lal, Jyotirmay Biswas & Komal Pathak. (2022) Clinical Profile and Risk Factors of Central Serous Chorioretinopathy in Al- Ain, United Arab Emirates. New Emirates Medical Journal 3:2.
Crossref
Tomoko Noda, Kousuke Noda, Kiriko Hirooka, Satoru Kase & Susumu Ishida. (2022) Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment. American Journal of Ophthalmology Case Reports 27, pages 101568.
Crossref
Rajan Singh Patheja. (2022) Serous macular detachments associated with topical travoprost. BMJ Case Reports 15:2, pages e246712.
Crossref
Suneeta Dubey, Kanika Jain & Saptarishi Mukhejee. (2022) Iridocorneal Endothelial Syndrome with Coexisting Macular Edema and Neurosensory Detachment: An Unusual Case Report. Journal of Current Glaucoma Practice 15:3, pages 149-152.
Crossref
Anil Parajuli & Purushottam Joshi. (2020) Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy. BMJ Open Ophthalmology 5:1, pages e000540.
Crossref
Isha Gupta, Luis Haddock & David S. Greenfield. (2020) Secondary open-angle glaucoma and serous macular detachment associated with pulmonary hypertension. American Journal of Ophthalmology Case Reports 20, pages 100878.
Crossref
Wenlan Zhang, Sumit Sharma, David A. Reichstein & Sharon Fekrat. (2018) Possible Herpetic Viral Association in Cases of Acute Exudative Polymorphous Vitelliform Maculopathy. Journal of VitreoRetinal Diseases 3:1, pages 31-35.
Crossref
Venkataramana Kalikivayi, Jerry Joseph, Blessy Thankom Mathews, Rajkumar Maheswari, Satyajit Mulanjur Vadakara & Sajeev Cherian Jacob. (2018) Reversal of retinal pigment epithelial detachment after cessation of topical travoprost therapy. International Ophthalmology 38:5, pages 2227-2231.
Crossref
Ozgur Artunay, Alper Sengul, Eda Sonmezay, Emil Gaffarli & Cigdem Kalaycik Ertugay. (2015) Central Serous Chorioretinopathy in Susac Syndrome. Journal of Neuro-Ophthalmology 35:2, pages 182-184.
Crossref
J. Costa & M. Farré. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 719 730 .
. (2013) Latanoprost. Reactions Weekly 1387:1, pages 23-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.